The evolution of the Dry Eye Syndrome Market is heavily influenced by advancements in biotechnology and ocular surface research. As the condition becomes more prevalent, pharmaceutical leaders are investing in biological agents that target the inflammatory pathways associated with tear deficiency. This scientific progression is essential for delivering improved patient satisfaction and...